A. Fromont, C. Binquet, E. A. Sauleau, I. Fournel, A. Bellisario et al., Geographic variations of multiple sclerosis in France, Brain, vol.133, pp.1889-99, 2010.

A. Compston and A. Coles, Multiple sclerosis, Lancet, vol.372, pp.1502-1519, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00996686

A. Nylander and D. A. Hafler, Multiple sclerosis, J Clin Invest, vol.122, pp.1180-1188, 2012.

J. H. Noseworthy, C. Lucchinetti, M. Rodriguez, and B. G. Weinshenker, Multiple sclerosis, N Engl J Med, vol.343, pp.938-52, 2000.

M. Sospedra and R. Martin, Immunology of multiple sclerosis, Annu Rev Immunol, vol.23, pp.683-747, 2005.

D. Laplaud and C. Confavreux,

, Rev Prat, vol.56, pp.1306-1318, 2006.

C. Pierrot-deseilligny and J. C. Souberbielle, Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?, Brain, vol.133, pp.1869-88, 2010.

Y. Schoindre, B. Terrier, J. E. Kahn, D. Saadoun, J. C. Souberbielle et al., Vitamine D et auto-immunité. Deuxième partie : aspects cliniques, Rev Med Interne, vol.33, pp.87-93, 2012.

P. A. Gourraud, H. F. Harbo, S. L. Hauser, and S. E. Baranzini, The genetics of multiple sclerosis: an up-to-date review, Immunol Rev, vol.248, pp.87-103, 2012.

T. M. Rivers, D. H. Sprunt, and G. P. Berry, Observation on attempts to produce acute disseminated encephalomyelitis in monkeys, J Exp Med, vol.58, pp.39-53, 1933.

H. Lassmann, Experimental models of multiple sclerosis, Rev Neurol (Paris), vol.163, pp.651-656, 2007.

H. Babbe, A. Roers, A. Waisman, H. Lassmann, N. Goebels et al., Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction, J Exp Med, vol.192, pp.393-404, 2000.

A. Junker, J. Ivanidze, J. Malotka, I. Eiglmeier, H. Lassmann et al., Multiple sclerosis: T-cell receptor expression in distinct brain regions, Brain, vol.130, pp.2789-99, 2007.

M. Montes, X. Zhang, L. Berthelot, D. A. Laplaud, S. Brouard et al., Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells, Clin Immunol, vol.130, pp.133-177, 2009.

E. Ngono, A. Pettré, S. Salou, M. Bahbouhi, B. Soulillou et al., Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients, Clin Immunol, vol.144, pp.117-143, 2012.

J. Goverman, Autoimmune T cell responses in the central nervous system, Nat Rev Immunol, vol.9, pp.393-407, 2009.

F. Petermann and T. Korn, Cytokines and effector T cell subsets causing autoimmune CNS disease, FEBS Letters, vol.585, pp.3747-57, 2011.

J. M. Fletcher, S. J. Lalor, C. M. Sweeney, N. Tubridy, and K. Mills, T cells in multiple sclerosis and experimental autoimmune encephalomyelitis, Clin Exp Immunol, vol.162, pp.1-11, 2010.

A. E. Lovett-racke, Y. Yang, and M. K. Racke, Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis?, Biochim Biophys Acta, vol.1812, pp.246-51, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00652650

H. S. Panitch, R. L. Hirsch, A. S. Haley, and K. P. Johnson, Exacerbations of multiple sclerosis in patients treated with gamma interferon, Lancet, vol.1, pp.893-898, 1987.

D. J. Cua, J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce et al., Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain, Nature, vol.421, pp.744-752, 2003.

L. Steinman, A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage, Nat Med, vol.13, pp.139-184, 2007.

B. Becher and B. M. Segal, T(H)17 cytokines in autoimmune neuro-inflammation, Curr Opin Immunol, vol.23, pp.707-719, 2011.

M. Samson, D. Lakomy, S. Audia, and B. Bonnotte, Les lymphocytes TH17 : différen-ciation, phénotype, fonctions, et implications en pathologie et thérapeutique humaine, Rev Med Interne, vol.32, pp.292-301, 2011.

C. L. Langrish, Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham et al., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation, J Exp Med, vol.201, pp.233-273, 2005.

F. Jadidi-niaragh and A. Mirshafiey, Th17 cell, the new player of neuroinflammatory process in multiple sclerosis, Scand J Immunol, vol.74, pp.1-13, 2011.

D. Matusevicius, P. Kivisäkk, B. He, N. Kostulas, V. Ozenci et al., Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis, Mult Scler, vol.5, pp.101-105, 1999.

J. S. Tzartos, M. A. Friese, M. J. Craner, J. Palace, J. Newcombe et al., Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis, Am J Pathol, vol.172, pp.146-55, 2008.

L. H. Kasper and J. Shoemaker, Multiple sclerosis immunology: the healthy immune system vs the MS immune system, Neurology, vol.74, pp.2-8, 2010.

H. F. Mcfarland and R. Martin, Multiple sclerosis: a complicated picture of autoimmunity, Nat Immunol, vol.8, pp.913-922, 2007.

R. A. O'connor, C. T. Prendergast, C. A. Sabatos, C. Lau, M. D. Leech et al., Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis, J Immunol, vol.181, pp.3750-3754, 2008.

M. A. Kroenke and B. M. Segal, IL-23 modulated myelin-specific T cells induce EAE via an IFN? driven IL-17 independent pathway, Brain Behav Immun, vol.25, pp.932-939, 2011.

M. A. Friese and L. Fugger, Pathogenic CD8(+) T cells in multiple sclerosis, Ann Neurol, vol.66, pp.132-173, 2009.

M. Jacobsen, S. Cepok, E. Quak, M. Happel, R. Gaber et al., Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients, Brain, vol.125, pp.538-50, 2002.

S. Jilek, M. Schluep, A. O. Rossetti, L. Guignard, L. Goff et al., CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis, Clin Immunol, vol.123, pp.105-118, 2007.

A. Saxena, G. Martin-blondel, L. T. Mars, and R. S. Liblau, Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis, FEBS Letters, vol.585, pp.3758-63, 2011.

I. Medana, M. A. Martinic, H. Wekerle, and H. Neumann, Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes, Am J Pathol, vol.159, pp.809-824, 2001.

H. Neumann, I. M. Medana, J. Bauer, and H. Lassmann, Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases, Trends Neurosci, vol.25, pp.313-322, 2002.

V. Annibali, G. Ristori, D. F. Angelini, B. Serafini, R. Mechelli et al., CD161(high)CD8+ T cells bear pathogenetic potential in multiple sclerosis, Brain, vol.134, issue.2, pp.542-54, 2011.

A. Reboldi, C. Coisne, D. Baumjohann, F. Benvenuto, D. Bottinelli et al., C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE, Nat Immunol, vol.10, pp.514-537, 2009.

L. Bourhis, L. , M. E. Péguillet, I. Guihot, A. Froux et al., Antimicrobial activity of mucosal-associated invariant T cells, Nat Immunol, vol.11, pp.701-709, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00550333

H. C. Von-büdingen, Bar-Or A, Zamvil SS. B cells in multiple sclerosis: connecting the dots, Curr Opin Immunol, vol.23, pp.713-733, 2011.

G. Disanto, J. M. Morahan, M. H. Barnett, G. Giovannoni, and S. V. Ramagopalan, The evidence for a role of B cells in multiple sclerosis, Neurology, vol.78, pp.823-855, 2012.

U. C. Meier, G. Giovannoni, J. S. Tzartos, and G. Khan, Translational mini-review series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein-Barr virus entry to the central nervous system?, Clin Exp Immunol, vol.167, pp.1-6, 2012.

R. Magliozzi, O. Howell, A. Vora, B. Serafini, R. Nicholas et al., Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology, Brain, vol.130, pp.1089-104, 2007.

L. Lovato, S. N. Willis, S. J. Rodig, T. Caron, S. E. Almendinger et al., Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis, Brain, vol.134, issue.2, pp.534-575, 2011.

B. Serafini, B. Rosicarelli, D. Franciotta, R. Magliozzi, R. Reynolds et al., Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain, J Exp Med, vol.204, pp.2899-912, 2007.

J. S. Tzartos, G. Khan, A. Vossenkamper, M. Cruz-sadaba, S. Lonardi et al., Association of innate immune activation with latent Epstein-Barr virus in active MS lesions, Neurology, vol.78, pp.15-23, 2012.

S. L. Hauser, E. Waubant, D. L. Arnold, T. Vollmer, J. Antel et al., B-cell depletion with rituximab in relapsing-remitting multiple sclerosis, N Engl J Med, vol.358, pp.676-88, 2008.

D. Zhou, R. Srivastava, S. Nessler, V. Grummel, N. Sommer et al., Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis, Proc Natl Acad Sci, vol.103, pp.19057-62, 2006.

C. T. Harp, S. Ireland, L. S. Davis, R. G. Cassidy, B. Cravens et al., Cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-? production in response to myelin basic protein and myelin oligodendrocyte glycoprotein, Eur J Immunol, vol.40, pp.2942-56, 2010.

M. E. Duddy and A. Alter, Bar-Or A. Distinct profiles of human B cell effector cytokines: a role in immune regulation?, J Immunol, vol.172, pp.3422-3429, 2004.

X. Zhang, D. N. Koldzic, L. Izikson, J. Reddy, R. F. Nazareno et al., IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+ CD4+ regulatory T cells, Int Immunol, vol.16, pp.249-56, 2004.

T. Matsushita, M. Horikawa, Y. Iwata, and T. F. Tedder, Regulatory B. cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis, J Immunol, vol.185, pp.2240-52, 2010.

K. Venken, N. Hellings, R. Liblau, and P. Stinissen, Disturbed regulatory T cell homeostasis in multiple sclerosis, Trends Mol Med, vol.16, pp.58-68, 2010.

D. E. Lowther and D. A. Hafler, Regulatory T cells in the central nervous system, Immunol Rev, vol.248, pp.156-69, 2012.

V. Viglietta, C. Baecher-allan, H. L. Weiner, and D. A. Hafler, Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients with multiple sclerosis, J Exp Med, vol.199, pp.971-980, 2004.

L. Michel, L. Berthelot, S. Pettré, S. Wiertlewski, F. Lefrère et al., Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis, J Clin Invest, vol.118, pp.3411-3420, 2008.

B. Fritzsching, J. Haas, F. König, P. Kunz, E. Fritzsching et al., Intracerebral human regulatory T cells: analysis of CD4+ CD25+ FOXP3+ T cells in brain lesions and cerebrospinal fluid of multiple sclerosis patients, PLoS One, vol.6, p.17988, 2011.

S. D. Wolf, B. N. Dittel, F. Hardardottir, J. Jr, and C. A. , Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice, J Exp Med, vol.184, pp.2271-2279, 1996.

C. Jamin, A. Morva, S. Lemoine, C. Daridon, A. R. De-mendoza et al., Lymphocytes in humans: a potential role in autoimmunity, Arthritis Rheum, vol.58, pp.1900-1906, 2008.

C. Mauri and A. Bosma, Immune regulatory function of B cells, Annu Rev Immunol, vol.30, pp.221-262, 2012.

S. Fillatreau, C. H. Sweenie, M. J. Mcgeachy, D. Gray, and S. M. Anderton, B cells regulate autoimmunity by provision of IL-10, Nat Immunol, vol.3, pp.944-50, 2002.

D. J. Dilillo, T. Matsushita, and T. F. Tedder, B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer, Ann NY Acad Sci, vol.1183, pp.38-57, 2010.

M. Duddy, M. Niino, F. Adatia, S. Hebert, M. Freedman et al., Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis, J Immunol, vol.178, pp.6092-6101, 2007.

Y. Iwata, T. Matsushita, M. Horikawa, D. J. Dilillo, K. Yanaba et al., Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells, Blood, vol.117, pp.530-571, 2011.

S. Knippenberg, E. Peelen, J. Smolders, M. Thewissen, P. Menheere et al., Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission, J Neuroimmunol, vol.239, pp.80-86, 2011.

R. Srivastava, M. Aslam, S. R. Kalluri, L. Schirmer, D. Buck et al., Potassium channel KIR4.1 as an immune target in multiple sclerosis, N Engl J Med, vol.367, pp.115-138, 2012.

A. K. Sewell, Why must T cells be cross-reactive?, Nat Rev Immunol, vol.12, pp.669-77, 2012.

R. M. Lucas, A. M. Hughes, M. Lay, A. Ponsonby, D. E. Dwyer et al., Epstein-Barr virus and multiple sclerosis, J Neurol Neurosurg Psychiatr, vol.82, pp.1142-1150, 2011.

Q. Ji, A. Perchellet, and J. M. Goverman, Viral infection triggers central nervous system autoimmunity via activation of CD8+ T cells expressing dual TCRs, Nat Immunol, vol.11, pp.628-662, 2010.

H. Kebir, K. Kreymborg, I. Ifergan, A. Dodelet-devillers, R. Cayrol et al., Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation, Nat Med, vol.13, pp.1173-1178, 2007.

C. Casiraghi, K. Dorovini-zis, and M. S. Horwitz, Epstein-Barr virus infection of human brain microvessel endothelial cells: a novel role in multiple sclerosis, J Neuroimmunol, vol.230, pp.173-180, 2011.

M. P. Pender, CD8+ T-cell deficiency, epstein-barr virus infection, vitamin d deficiency, and steps to autoimmunity: a unifying hypothesis, Autoimmune Dis, p.189096, 2012.

M. H. Barnett and J. W. Prineas, Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion, Ann Neurol, vol.55, pp.458-68, 2004.